UC Davis Medical Center - UC Davis Comprehensive Cancer Center - Hemotology/Oncology Clinic
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gam, Stephanie
NCT02670707: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Recruiting
3
124
US
Cytarabine, cytosine arabinoside (ara-C), Vinblastine/prednisone, Velban/Deltasone
Baylor College of Medicine
Langerhans Cell Histiocytosis
01/25
01/29
Bronte-Hall, Lanetta
HIBISCUS, NCT04624659 / 2020-003884-25: A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease

Recruiting
2/3
344
Europe, Canada, US, RoW
Etavopivat Tablets Low dose, FT-4202, Etavopivat Tablets High dose, Placebo Tablets, placebo, Etavopivat Tablets
Forma Therapeutics, Inc., Novo Nordisk A/S
Sickle Cell Disease
03/26
04/27
NCT05169580: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FTX-6058

Recruiting
1
70
US, RoW
FTX-6058 oral capsule(s)
Fulcrum Therapeutics
Sickle Cell Disease, Sickle Cell Anemia
04/25
04/25
Aguirre, Alfredo Lopez
HIBISCUS, NCT04624659 / 2020-003884-25: A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease

Recruiting
2/3
344
Europe, Canada, US, RoW
Etavopivat Tablets Low dose, FT-4202, Etavopivat Tablets High dose, Placebo Tablets, placebo, Etavopivat Tablets
Forma Therapeutics, Inc., Novo Nordisk A/S
Sickle Cell Disease
03/26
04/27
Huie, Sharon
HIBISCUS, NCT04624659 / 2020-003884-25: A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease

Recruiting
2/3
344
Europe, Canada, US, RoW
Etavopivat Tablets Low dose, FT-4202, Etavopivat Tablets High dose, Placebo Tablets, placebo, Etavopivat Tablets
Forma Therapeutics, Inc., Novo Nordisk A/S
Sickle Cell Disease
03/26
04/27
NCT05317000: 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Recruiting
2
50
US
Combination 5-azacytidine and nivolumab, Vidaza and Opdivo, 5-azacytidine, Vidaza, Nivolumab, Opdivo
Barbara Burtness, National Institute of Dental and Craniofacial Research (NIDCR)
Squamous Cell Carcinoma of Head and Neck
09/25
02/26
Haakenson, Priscilla
HIBISCUS, NCT04624659 / 2020-003884-25: A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease

Recruiting
2/3
344
Europe, Canada, US, RoW
Etavopivat Tablets Low dose, FT-4202, Etavopivat Tablets High dose, Placebo Tablets, placebo, Etavopivat Tablets
Forma Therapeutics, Inc., Novo Nordisk A/S
Sickle Cell Disease
03/26
04/27
NCT05322850: Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Recruiting
1/2
40
US
Orca-Q
University of Florida, Orca Biosystems, Inc., Florida Department of Health
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Acute Undifferentiated Leukemia, Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis), Chronic Myeloid Leukemia - Accelerated Phase
09/26
09/27

Download Options